Policy considerations in designing a fragile X population screening program.
Ross
Lainie Friedman
LF
Departments of Pediatrics, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, Illinois 60637, USA. lross@uchicago.edu
Acharya
Kruti
K
D005600:Fragile X Syndrome / Q000175:diagnosis* / Q000235:genetics; D005820:Genetic Testing / Q000941:ethics / Q000331:legislation & jurisprudence*; D006291:Health Policy; D006801:Humans